to study the reduction of inflammation in corneal graft by cyclosporine and talimus topical drugs
Not Applicable
- Conditions
- Health Condition 1: H160- Corneal ulcer
- Registration Number
- CTRI/2020/06/026208
- Lead Sponsor
- Dr Prashant Borde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Cases of Therapeutic Keratoplasty in patients of fungal keratitis.
2. Cases of TPK with graft size 11 mm or less.
3. Cases of TPK with graft cell count more than 1600 cells/mm3
4. Patients willing for giving consent in the study.
Exclusion Criteria
1. Cases of therapeutic keratoplasty having graft size 12 mm or more
2. Cases with posterior segment involvement having moderate to severe vitritis.
3. Cases not giving consent for study.
4. Cases having known allergic reaction to either drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method